Diosgenin

Spécifications

512-04-9Numéro CAS

208-134-3Numéro CE

(1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-olNom IUPAC

C27H42O3Formule chimique

414.6 g/molMasse molaire

DIOSGENIN; 512-04-9; Nitogenin; (3beta,25R)-spirost-5-en-3-ol; K49P2K8WLX; CHEBI:4629; DTXSID00895074; (25R)-spirost-5-en-3beta-diol; Spirost-5-en-3-ol, (3beta,25R)-; NSC-33396; (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro(5-oxapentacyclo(10.8.0.02,9.04,8.013,18)icos-18-ene-6,2'-oxane)-16-ol; (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-ol; RefChem:5766; DTXCID301324626; 208-134-3; Diosgenine; MFCD00016887; DISOGENIN; (25R)-Spirost-5-en-3beta-ol; (2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-Tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol; (20R,25R)-Spirost-5-en-3beta-ol; NSC 33396; (25R)-14beta,17beta-spirost-5-en-3beta-ol; SP 37; Spirost-5-en-3beta-ol, (25R)-; UNII-K49P2K8WLX; Spirost-5-en-3-ol, (3b,25R)-; nitrogen in; CCRIS 6803; Diosgenin CRS; 22alpha-Spirost-5-en-3beta-ol; (7S,8S,10S,13S,15S,18S,22S,3R,12R,14R,19R)-3,13,15,19-tetramethyl-11-oxaspiro[ 2H-3,4,5,6-tetrahydropyran-6,6'-pentacyclo[10.8.0.0<2,9>.0<4,8>.0<13,18>]icosa ne]-24-en-22-ol; YUV; EINECS 208-134-3; Diosgenin (Standard); BRN 0094582; Diosgenin, >=93%; DIOSGENIN [MI]; 3A-Hydroxy-5-spirostene; 3?-Hydroxy-5-spirostene; DIOSGENIN [WHO-DD]; SCHEMBL83359; 5-19-03-00030 (Beilstein Handbook Reference); (25R)-5-Spirosten-3b-ol; (25R)-5-Spirosten-3A-ol; CHEMBL412437; orb1304911; orb3140633; HY-N0177R; WLZ4700; HY-N0177; BDBM50617158; EBC-50097; LMST01080037; MSK159048; SBB058140; (3|_,25R)-spirost-5-en-3-ol; (3|A,25R)-Spirost-5-en-3-ol; AKOS015961083; Spirost-5-en-3-beta-ol, (25R)-; CS-5303; NCGC00386027-01; Spirost-5-en-3-ol, (3-beta,25R)-; AS-13640; ST097775; SY015253; NS00014256; S2291; (3.BETA.,25R)-SPIROST-5-EN-3-OL; C08898; M03858; EN300-7388351; F012718; doi:10.14272/WQLVFSAGQJTQCK-VKROHFNGSA-N.1; Q1107734; BRD-K28690501-001-02-1; DIOSGENIN (CONSTITUENT OF FENUGREEK SEED) [DSC]; Z1741961122; Diosgenin, European Pharmacopoeia (EP) Reference Standard; (25R)-5-Spirosten-3(1/4)?-ol ; 3(1/4)?-Hydroxy-5-spirostene; (1'S,2R,2'S,4'S,5R,7'S,8'R,9'S,12'S,13'R,16'S)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosan]-18'-en-16'-ol; (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-tetrahydropyran]-16-olSynonymes